142 related articles for article (PubMed ID: 10859012)
21. Liposomal doxorubicin with and without TNFalpha in the perfusional treatment of advanced soft tissue limb sarcoma: preliminary results.
Di Filippo F; Anzà M; Garinei R; Cavaliere F; Perri P; Botti C; Di Angelo P; Di Filippo S; Maini CL; Pasqualoni R; Di Segni S; Colantonio S; Bruno P; Piarulli L; Principi F
In Vivo; 2006; 20(6A):735-8. PubMed ID: 17203757
[TBL] [Abstract][Full Text] [Related]
22. Concomitant radiation-doxorubicin administration in locally advanced and/or metastatic soft tissue sarcomas: preliminary results.
Toma S; Palumbo R; Sogno G; Canavese G; Barra S; Marziano C; Serrano J; Albanese E; Rosso R
Anticancer Res; 1991; 11(6):2085-9. PubMed ID: 1776844
[TBL] [Abstract][Full Text] [Related]
23. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
Lorigan P; Verweij J; Papai Z; Rodenhuis S; Le Cesne A; Leahy MG; Radford JA; Van Glabbeke MM; Kirkpatrick A; Hogendoorn PC; Blay JY;
J Clin Oncol; 2007 Jul; 25(21):3144-50. PubMed ID: 17634494
[TBL] [Abstract][Full Text] [Related]
24. A phase II study of caelyx, liposomal doxorubicin: lack of activity in patients with advanced gastric cancer.
Thomas AL; O'Byrne K; Furber L; Jeffery K; Steward WP
Cancer Chemother Pharmacol; 2001 Oct; 48(4):266-8. PubMed ID: 11710625
[TBL] [Abstract][Full Text] [Related]
25. Concomitant liposomal doxorubicin and daily palliative radiotherapy in advanced feline soft tissue sarcomas.
Kleiter M; Tichy A; Willmann M; Pagitz M; Wolfesberger B
Vet Radiol Ultrasound; 2010; 51(3):349-55. PubMed ID: 20469561
[TBL] [Abstract][Full Text] [Related]
26. High-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas.
Yalcin B; Pamir A; Buyukcelik A; Utkan G; Akbulut H; Demirkazik A; Icli F
Exp Oncol; 2004 Dec; 26(4):320-5. PubMed ID: 15627067
[TBL] [Abstract][Full Text] [Related]
27. Long-term results of preoperative intra-arterial doxorubicin combined with neoadjuvant radiotherapy, followed by extensive surgical resection for locally advanced soft tissue sarcomas of the extremities.
Nijhuis PH; Pras E; Sleijfer DT; Molenaar WM; Koops HS; Hoekstra HJ
Radiother Oncol; 1999 Apr; 51(1):15-9. PubMed ID: 10386712
[TBL] [Abstract][Full Text] [Related]
28. Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study.
Zalupski M; Metch B; Balcerzak S; Fletcher WS; Chapman R; Bonnet JD; Weiss GR; Ryan J; Benjamin RS; Baker LH
J Natl Cancer Inst; 1991 Jul; 83(13):926-32. PubMed ID: 2067035
[TBL] [Abstract][Full Text] [Related]
29. Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors.
Hauck ML; LaRue SM; Petros WP; Poulson JM; Yu D; Spasojevic I; Pruitt AF; Klein A; Case B; Thrall DE; Needham D; Dewhirst MW
Clin Cancer Res; 2006 Jul; 12(13):4004-10. PubMed ID: 16818699
[TBL] [Abstract][Full Text] [Related]
30. Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma.
Lyass O; Uziely B; Ben-Yosef R; Tzemach D; Heshing NI; Lotem M; Brufman G; Gabizon A
Cancer; 2000 Sep; 89(5):1037-47. PubMed ID: 10964334
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies.
Gabizon A; Shmeeda H; Barenholz Y
Clin Pharmacokinet; 2003; 42(5):419-36. PubMed ID: 12739982
[TBL] [Abstract][Full Text] [Related]
32. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours.
Gabizon A; Martin F
Drugs; 1997; 54 Suppl 4():15-21. PubMed ID: 9361957
[TBL] [Abstract][Full Text] [Related]
33. Addition of low-dose tumor necrosis factor-alpha to systemic treatment with STEALTH liposomal doxorubicin (Doxil) improved anti-tumor activity in osteosarcoma-bearing rats.
Hoving S; Seynhaeve AL; van Tiel ST; Eggermont AM; ten Hagen TL
Anticancer Drugs; 2005 Jul; 16(6):667-74. PubMed ID: 15930896
[TBL] [Abstract][Full Text] [Related]
34. Concomitant chemo-radiotherapy in the treatment of locally advanced and/or metastatic soft tissue sarcomas: experience of the National Cancer Institute of Genoa.
Toma S; Canavese G; Grimaldi A; Ravera G; Ugolini D; Percivale P; Badellino F
Oncol Rep; 2003; 10(3):641-7. PubMed ID: 12684637
[TBL] [Abstract][Full Text] [Related]
35. Liposomal doxorubicin (Caelyx) in symptomatic androgen-independent prostate cancer (AIPC)--delayed response and flare phenomenon should be considered.
Fosså SD; Vaage S; Letocha H; Iversen J; Risberg T; Johannessen DC; Paus E; Smedsrud T;
Scand J Urol Nephrol; 2002 Feb; 36(1):34-9. PubMed ID: 12002355
[TBL] [Abstract][Full Text] [Related]
36. Preoperative isolated limb infusion of Doxorubicin and external irradiation for limb-threatening soft tissue sarcomas.
Hegazy MA; Kotb SZ; Sakr H; El Dosoky E; Amer T; Hegazi RA; Farouk O
Ann Surg Oncol; 2007 Feb; 14(2):568-76. PubMed ID: 17094027
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.
Edmonson JH; Petersen IA; Shives TC; Mahoney MR; Rock MG; Haddock MG; Sim FH; Maples WJ; O'Connor MI; Gunderson LL; Foo ML; Pritchard DJ; Buckner JC; Stafford SL
Cancer; 2002 Feb; 94(3):786-92. PubMed ID: 11857314
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer.
Gordon AN; Granai CO; Rose PG; Hainsworth J; Lopez A; Weissman C; Rosales R; Sharpington T
J Clin Oncol; 2000 Sep; 18(17):3093-100. PubMed ID: 10963637
[TBL] [Abstract][Full Text] [Related]
39. Phase I study of pegylated liposomal doxorubicin (Caelyx) in combination with carboplatin in patients with advanced solid tumors.
Gonçalves A; Braud AC; Viret F; Genre D; Gravis G; Tarpin C; Giovannini M; Maraninchi D; Viens P
Anticancer Res; 2003; 23(4):3543-8. PubMed ID: 12926104
[TBL] [Abstract][Full Text] [Related]
40. A phase I trial of AUC-directed carboplatin with infusional doxorubicin and ifosfamide plus G-CSF in patients with advanced gynecologic malignancies.
Lopez AM; Ketchum M; Nichols H; Xu MJ; Peng YM; Dorr R; Alberts DS
Cancer Chemother Pharmacol; 2000; 46(5):411-5. PubMed ID: 11127946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
